{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T08:18:35Z","timestamp":1783498715338,"version":"3.55.0"},"reference-count":60,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,12]],"date-time":"2026-06-12T00:00:00Z","timestamp":1781222400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["eBioMedicine"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/j.ebiom.2026.106355","type":"journal-article","created":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T16:39:40Z","timestamp":1782751180000},"page":"106355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["A preS2 aa1\u201326-specific humoural response marks functional cure in chronic HBV infection"],"prefix":"10.1016","volume":"129","author":[{"given":"You-Yuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun-Liang","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Xin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong-Min","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shan-Quan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zi-Wei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming-Ju","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Zhe","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng-Meng","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Xuan","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Si-Yuan","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruo-Nan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Mei","family":"Jiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Wen","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheng","family":"Zhen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fu-Sheng","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8126-8145","authenticated-orcid":false,"given":"Chao","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"10381","key":"10.1016\/j.ebiom.2026.106355_bib1","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1016\/S0140-6736(22)01468-4","article-title":"Hepatitis B","volume":"401","author":"Jeng","year":"2023","journal-title":"Lancet"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106355_bib2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.jhep.2018.10.014","article-title":"HBsAg seroclearance further reduces hepatocellular carcinoma risk after complete viral suppression with nucleos(t)ide analogues","volume":"70","author":"Yip","year":"2019","journal-title":"J Hepatol"},{"issue":"22","key":"10.1016\/j.ebiom.2026.106355_bib3","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1056\/NEJMoa2405485","article-title":"Xalnesiran with or without an immunomodulator in chronic hepatitis B","volume":"391","author":"Hou","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2026.106355_bib4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1038\/s41591-025-04049-z","article-title":"Elebsiran and PEG-IFN\u03b1 for chronic hepatitis B infection: a partially randomized, open-label, phase 2 trial","volume":"32","author":"Wong","year":"2026","journal-title":"Nat Med"},{"key":"10.1016\/j.ebiom.2026.106355_bib5","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1136\/gutjnl-2025-336592","article-title":"Peginterferon alpha-2a add-on to siRNA JNJ-73763989 in untreated patients with HBeAg-positive chronic hepatitis B virus (HBV) infection: the phase 2 REEF-IT study","volume":"75","author":"Kennedy","year":"2026","journal-title":"Gut"},{"key":"10.1016\/j.ebiom.2026.106355_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2025-336251","article-title":"HBsAg decline and clearance with peg-IFN therapy added to nucleos(t)ide analogues: an individual participant data meta-analysis of prospective trials (PROSPER)","author":"Dongelmans","year":"2025","journal-title":"Gut"},{"key":"10.1016\/j.ebiom.2026.106355_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2025-337336","article-title":"PEG is back: revisiting the role of pegylated interferon alfa and benchmarking its place in HBV cure strategies","author":"Cornberg","year":"2026","journal-title":"Gut"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106355_bib8","article-title":"Humoral immunity in hepatitis B virus infection: rehabilitating the B in HBV","volume":"4","author":"Vanwolleghem","year":"2022","journal-title":"JHEP Rep"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106355_bib9","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1056\/NEJM200101043440120","article-title":"Acute hepatitis B in a patient with antibodies to hepatitis B surface antigen who was receiving rituximab","volume":"344","author":"Dervite","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ebiom.2026.106355_bib10","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.jhep.2025.03.018","article-title":"Electronic address eee, and European association for the study of the L. EASL clinical practice guidelines on the management of hepatitis B virus infection","volume":"83","year":"2025","journal-title":"J Hepatol"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106355_bib11","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2023.2259003","article-title":"The presence of baseline HBsAb-Specific B cells can predict HBsAg or HBeAg seroconversion of chronic hepatitis B on treatment","volume":"12","author":"Yin","year":"2023","journal-title":"Emerg Microbes Infect"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106355_bib12","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.cgh.2019.04.020","article-title":"Durability of interferon-induced hepatitis B surface antigen seroclearance","volume":"18","author":"Wu","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106355_bib13","doi-asserted-by":"crossref","first-page":"4588","DOI":"10.1172\/JCI121960","article-title":"Circulating and intrahepatic antiviral B cells are defective in hepatitis B","volume":"128","author":"Burton","year":"2018","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106355_bib14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jhep.2019.07.015","article-title":"Comparative characterization of B cells specific for HBV nucleocapsid and envelope proteins in patients with chronic hepatitis B","volume":"72","author":"Le Bert","year":"2020","journal-title":"J Hepatol"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106355_bib15","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jhep.2024.06.033","article-title":"Varied immune responses of HBV-specific B cells in patients undergoing pegylated interferon-alpha treatment for chronic hepatitis B","volume":"81","author":"Zhang","year":"2024","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106355_bib16","doi-asserted-by":"crossref","DOI":"10.1080\/22221751.2024.2409350","article-title":"Circulating HBsAg-specific B cells are partially rescued in chronically HBV-infected patients with functional cure","volume":"13","author":"Gu","year":"2024","journal-title":"Emerg Microbes Infect"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106355_bib17","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1007\/s12072-025-10846-y","article-title":"Single-cell transcriptomic profiling reveals dysregulation of B-cell subset function in patients with chronic hepatitis B","volume":"19","author":"Li","year":"2025","journal-title":"Hepatol Int"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106355_bib18","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/cmi.2015.25","article-title":"Reversal of B-cell hyperactivation and functional impairment is associated with HBsAg seroconversion in chronic hepatitis B patients","volume":"12","author":"Xu","year":"2015","journal-title":"Cell Mol Immunol"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106355_bib19","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jhep.2020.08.039","article-title":"Composition of HBsAg is predictive of HBsAg loss during treatment in patients with HBeAg-positive chronic hepatitis B","volume":"74","author":"Pfefferkorn","year":"2021","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106355_bib20","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1053\/j.gastro.2014.04.030","article-title":"Strategies to inhibit entry of HBV and HDV into hepatocytes","volume":"147","author":"Urban","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.ebiom.2026.106355_bib21","article-title":"Sodium taurocholate cotransporting polypeptide is a functional receptor for human hepatitis B and D virus","volume":"1","author":"Zhong","year":"2012","journal-title":"ELife"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106355_bib22","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.jhep.2021.07.031","article-title":"Role of anti-HBs in functional cure of HBeAg+ chronic hepatitis B patients infected with HBV genotype A","volume":"76","author":"Xu","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/j.ebiom.2026.106355_bib23","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.767000","article-title":"Identification and mapping of HBsAg loss-related B-Cell linear epitopes in chronic HBV patients by peptide array","volume":"12","author":"Gu","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/j.ebiom.2026.106355_bib24","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.immuni.2024.04.014","article-title":"Antigen-level resolution of commensal-specific B cell responses can be enabled by phage display screening coupled with B cell tetramers","volume":"57","author":"Verma","year":"2024","journal-title":"Immunity"},{"issue":"6239","key":"10.1016\/j.ebiom.2026.106355_bib25","doi-asserted-by":"crossref","DOI":"10.1126\/science.aaa0698","article-title":"Comprehensive serological profiling of human populations using a synthetic human virome","volume":"348","author":"Xu","year":"2015","journal-title":"Science"},{"issue":"9","key":"10.1016\/j.ebiom.2026.106355_bib26","doi-asserted-by":"crossref","first-page":"1958","DOI":"10.1038\/s41596-018-0025-6","article-title":"PhIP-Seq characterization of serum antibodies using oligonucleotide-encoded peptidomes","volume":"13","author":"Mohan","year":"2018","journal-title":"Nat Protoc"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106355_bib27","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1016\/j.immuni.2022.05.002","article-title":"Phage display of environmental protein toxins and virulence factors reveals the prevalence, persistence, and genetics of antibody responses","volume":"55","author":"Angkeow","year":"2022","journal-title":"Immunity"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106355_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhepr.2021.100388","article-title":"Characterization of the liver immune microenvironment in liver biopsies from patients with chronic HBV infection","volume":"4","author":"van Buuren","year":"2022","journal-title":"JHEP Reports"},{"issue":"3","key":"10.1016\/j.ebiom.2026.106355_bib29","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1038\/s41596-023-00930-8","article-title":"Production and use of antigen tetramers to study antigen-specific B cells","volume":"19","author":"Phelps","year":"2024","journal-title":"Nat Protoc"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106355_bib30","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1016\/j.cell.2022.04.009","article-title":"Efficient recall of Omicron-reactive B cell memory after a third dose of SARS-CoV-2 mRNA vaccine","volume":"185","author":"Goel","year":"2022","journal-title":"Cell"},{"issue":"24","key":"10.1016\/j.ebiom.2026.106355_bib31","doi-asserted-by":"crossref","first-page":"7400","DOI":"10.3748\/wjg.v21.i24.7400","article-title":"Applications of human hepatitis B virus preS domain in bio- and nanotechnology","volume":"21","author":"Toita","year":"2015","journal-title":"World J Gastroenterol"},{"issue":"11","key":"10.1016\/j.ebiom.2026.106355_bib32","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1136\/gutjnl-2017-313811","article-title":"Quantification of large and middle proteins of hepatitis B virus surface antigen (HBsAg) as a novel tool for the identification of inactive HBV carriers","volume":"67","author":"Pfefferkorn","year":"2018","journal-title":"Gut"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106355_bib33","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/infdis\/jiy119","article-title":"Divergent preS Sequences in Virion-Associated Hepatitis B Virus Genomes and Subviral HBV Surface Antigen Particles From HBV e Antigen-Negative Patients","volume":"218","author":"Peiffer","year":"2018","journal-title":"J Infect Dis"},{"issue":"Pt 2","key":"10.1016\/j.ebiom.2026.106355_bib34","first-page":"369","article-title":"Mapping of immunodominant B-cell epitopes and the human serum albumin-binding site in natural hepatitis B virus surface antigen of defined genosubtype","volume":"81","author":"Sobotta","year":"2000","journal-title":"J Gen Virol"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106355_bib35","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/jmv.1890460210","article-title":"Quantitative assessment of IgM antibodies towards an immunodominant B-cell epitope within the preS2 domain of HBV in the natural course and during combined prednisone\/interferon alpha 2b treatment of chronic hepatitis B virus infection","volume":"46","author":"Fei","year":"1995","journal-title":"J Med Virol"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106355_bib36","doi-asserted-by":"crossref","DOI":"10.1128\/jvi.01929-23","article-title":"Both middle and large envelope proteins can mediate neutralization of hepatitis B virus infectivity by anti-preS2 antibodies: escape by naturally occurring preS2 deletions","volume":"98","author":"Zhang","year":"2024","journal-title":"J Virol"},{"issue":"7","key":"10.1016\/j.ebiom.2026.106355_bib37","doi-asserted-by":"crossref","first-page":"5573","DOI":"10.1128\/JVI.72.7.5573-5578.1998","article-title":"Role of the pre-S2 domain of the large envelope protein in hepatitis B virus assembly and infectivity","volume":"72","author":"Le Seyec","year":"1998","journal-title":"J Virol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106355_bib38","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0264-410X(86)80001-9","article-title":"Antibodies to a synthetic peptide from the preS 120-145 region of the hepatitis B virus envelope are virus neutralizing","volume":"4","author":"Neurath","year":"1986","journal-title":"Vaccine"},{"issue":"23","key":"10.1016\/j.ebiom.2026.106355_bib39","doi-asserted-by":"crossref","first-page":"9174","DOI":"10.1073\/pnas.83.23.9174","article-title":"A synthetic peptide vaccine involving the product of the pre-S(2) region of hepatitis B virus DNA: protective efficacy in chimpanzees","volume":"83","author":"Itoh","year":"1986","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106355_bib40","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/0168-1656(92)90100-N","article-title":"Identification of polymerized-albumin receptor domain in the pre-S2 region of hepatitis B virus surface antigen M protein","volume":"23","author":"Itoh","year":"1992","journal-title":"J Biotechnol"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106355_bib41","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1007\/s00705-016-2980-y","article-title":"Localization of immunodominant epitopes within the \"a\" determinant of hepatitis B surface antigen using monoclonal antibodies","volume":"161","author":"Golsaz-Shirazi","year":"2016","journal-title":"Arch Virol"},{"issue":"8","key":"10.1016\/j.ebiom.2026.106355_bib42","doi-asserted-by":"crossref","first-page":"2703","DOI":"10.4049\/jimmunol.137.8.2703","article-title":"Two distinct but overlapping antibody binding sites in the pre-S(2) region of HBsAg localized within 11 continuous residues","volume":"137","author":"Milich","year":"1986","journal-title":"J Immunol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106355_bib43","doi-asserted-by":"crossref","DOI":"10.1080\/21645515.2024.2445283","article-title":"The significance of antibody to hepatitis B surface antigen in infection and clearance of hepatitis B virus","volume":"21","author":"Ding","year":"2025","journal-title":"Hum Vaccin Immunother"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106355_bib44","doi-asserted-by":"crossref","first-page":"4573","DOI":"10.1172\/JCI121957","article-title":"PD-1 blockade partially recovers dysfunctional virus-specific B cells in chronic hepatitis B infection","volume":"128","author":"Salimzadeh","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/j.ebiom.2026.106355_bib45","doi-asserted-by":"crossref","DOI":"10.1136\/gutjnl-2024-333309","article-title":"Tracking B cell immunity during perturbation of hepatitis B infection induced by treatment withdrawal","author":"Lens","year":"2025","journal-title":"Gut"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106355_bib46","doi-asserted-by":"crossref","first-page":"4257","DOI":"10.1172\/JCI124098","article-title":"Entering the spotlight: hepatitis B surface antigen-specific B cells","volume":"128","author":"Neumann-Haefelin","year":"2018","journal-title":"J Clin Invest"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106355_bib47","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s12072-024-10753-8","article-title":"Functional B cell deficiency promotes intrahepatic HBV replication and impairs the development of anti-HBV T cell responses","volume":"19","author":"Zhu","year":"2025","journal-title":"Hepatol Int"},{"key":"10.1016\/j.ebiom.2026.106355_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.virusres.2022.199014","article-title":"Identification of neutralizing epitopes in the preS2 domain of the hepatitis B virus","volume":"323","author":"Yato","year":"2023","journal-title":"Virus Res"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106355_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2025.116705","article-title":"In vivo efficacy of combined human broadly neutralizing antibodies against hepatitis B virus","volume":"44","author":"Beretta","year":"2025","journal-title":"Cell Rep"},{"issue":"4","key":"10.1016\/j.ebiom.2026.106355_bib50","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1053\/j.gastro.2006.01.011","article-title":"High prevalence and mapping of pre-S deletion in hepatitis B virus carriers with progressive liver diseases","volume":"130","author":"Chen","year":"2006","journal-title":"Gastroenterology"},{"issue":"5","key":"10.1016\/j.ebiom.2026.106355_bib51","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1111\/apt.18448","article-title":"Virological and immunological characteristics of HBeAg-Positive chronic hepatitis B patients with low HBsAg levels","volume":"61","author":"Chen","year":"2025","journal-title":"Aliment Pharmacol Ther"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106355_bib52","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1002\/hep.31789","article-title":"Clinical implications of HBV PreS\/S mutations and the effects of PreS2 deletion on mitochondria, liver fibrosis, and cancer development","volume":"74","author":"Liang","year":"2021","journal-title":"Hepatology"},{"issue":"18","key":"10.1016\/j.ebiom.2026.106355_bib53","doi-asserted-by":"crossref","DOI":"10.1172\/JCI161818","article-title":"Integrated hepatitis B virus DNA maintains surface antigen production during antiviral treatment","volume":"132","author":"Grudda","year":"2022","journal-title":"J Clin Invest"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106355_bib54","doi-asserted-by":"crossref","DOI":"10.1172\/JCI184243","article-title":"Transcription of hepatitis B surface antigen shifts from cccDNA to integrated HBV DNA during treatment","volume":"135","author":"Taddese","year":"2025","journal-title":"J Clin Invest"},{"issue":"10","key":"10.1016\/j.ebiom.2026.106355_bib55","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1111\/apt.17670","article-title":"Integrated HBV DNA and cccDNA maintain transcriptional activity in intrahepatic HBsAg-positive patients with functional cure following PEG-IFN-based therapy","volume":"58","author":"Gao","year":"2023","journal-title":"Aliment Pharmacol Ther"},{"issue":"6","key":"10.1016\/j.ebiom.2026.106355_bib56","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1016\/j.jhep.2024.06.037","article-title":"Hepatitis B virus DNA integration: implications for diagnostics, therapy, and outcome","volume":"81","author":"Zoulim","year":"2024","journal-title":"J Hepatol"},{"issue":"1","key":"10.1016\/j.ebiom.2026.106355_bib57","doi-asserted-by":"crossref","first-page":"8515","DOI":"10.1038\/s41467-025-63497-w","article-title":"Episomal and integrated hepatitis B transcriptome mapping uncovers heterogeneity with the potential for drug-resistance","volume":"16","author":"Harris","year":"2025","journal-title":"Nat Commun"},{"issue":"12","key":"10.1016\/j.ebiom.2026.106355_bib58","doi-asserted-by":"crossref","DOI":"10.1111\/cmi.13399","article-title":"Hepatitis B virus envelope proteins can serve as therapeutic targets embedded in the host cell plasma membrane","volume":"23","author":"Zhao","year":"2021","journal-title":"Cell Microbiol"},{"issue":"2","key":"10.1016\/j.ebiom.2026.106355_bib59","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1002\/jmv.1890200204","article-title":"Monoclonal antibody recognizing pre-S(2) epitope of hepatitis B virus: characterization of pre-S(2) epitope and anti-pre-S(2) antibody","volume":"20","author":"Budkowska","year":"1986","journal-title":"J Med Virol"},{"key":"10.1016\/j.ebiom.2026.106355_bib60","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.jhep.2025.08.016","article-title":"Engineered monoclonal antibody tobevibart enhances HBsAg capture by Fc receptor-positive cells and activates HBV-specific T cells","volume":"84","author":"Vincenzetti","year":"2026","journal-title":"J Hepatol"}],"container-title":["eBioMedicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426002380?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2352396426002380?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T08:11:54Z","timestamp":1783498314000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2352396426002380"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7]]},"references-count":60,"alternative-id":["S2352396426002380"],"URL":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106355","relation":{},"ISSN":["2352-3964"],"issn-type":[{"value":"2352-3964","type":"print"}],"subject":[],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A preS2 aa1\u201326-specific humoural response marks functional cure in chronic HBV infection","name":"articletitle","label":"Article Title"},{"value":"eBioMedicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ebiom.2026.106355","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier B.V.","name":"copyright","label":"Copyright"}],"article-number":"106355"}}